Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-000411
Filing Date
2020-01-16
Accepted
2020-01-16 16:44:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 32051
2 filename2.txt TEXT-EXTRACT 1212
  Complete submission text file 0000000000-20-000411.txt   46304
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Filed for) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations